Windows of operation for bioreactor design for the controlled formation of tissue-engineered arteries

Biotechnology Progress

Volumn 25, Issue 3, 2009, Pages 842-853

  Gerontas, Spyridon ^a   Farid, Suzanne S ^a   Hoare, Michael ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alginate; Artificial artery; Bioreactor; Tissue engineering; Vascular tissue; Windows of operation

Indexed keywords

ARTIFICIAL ARTERY; BIOREACTOR DESIGN; BYPASS SURGERY; CELL CONCENTRATIONS; CELLULAR TRANSPORT; CLINICAL MANAGEMENT; CONTOUR PLOT; CRITICAL FLOW RATE; EFFECTIVE DIFFUSIVITIES; FEED-RATES; IN-VITRO; METABOLITE CONCENTRATIONS; OPERATING CONDITION; PHYSIOLOGICAL ENVIRONMENT; RECYCLE RATE; STEM CELL; TISSUE-ENGINEERED ARTERY; TRANSPORT PHENOMENA; TUBE GEOMETRY; TUBULAR SCAFFOLD; VASCULAR TISSUE;

ALGINATE; BIOCONVERSION; BIOREACTORS; BLOOD VESSEL PROSTHESES; CELL MEMBRANES; INDUSTRIAL CHEMICALS; OXYGEN; TISSUE; WINDOWS;

TISSUE ENGINEERING;

ARTERY; ARTICLE; BIOLOGICAL MODEL; BIOREACTOR; CHEMISTRY; CULTURE TECHNIQUE; EVALUATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; METHODOLOGY; TISSUE ENGINEERING;

ARTERIES; BIOREACTORS; CELL CULTURE TECHNIQUES; HUMANS; MODELS, BIOLOGICAL; TISSUE ENGINEERING;

EID: 67651102465     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.140     Document Type: Article

References (59)

1. World Health Organization. World Health Organization: The World Health Report 1999. Geneva, Switzerland: World Health Organization; 1999.
2. Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion. Operative technique. Ann Thorac Surg. 1968;5:334-339.
3. Campeau L, Enjalbert M, Lesperance J, Bourassa MG, Kwiterovich P, Wacholder S, Sniderman A. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med. 1984;311:1329-1332.
4. Greenwald SE, Berry CL. Improving vascular grafts: the importance of mechanical and haemodynamic properties. J Pathol.2000;190:292-299.
5. Ratcliffe A. Tissue engineering of vascular grafts. Matrix Biol.2000;19:353-357.
6. Stock UA, Vacanti JP. Tissue engineering: current state and prospects. Annu Rev Med. 2001;52:443-451.
7. Teebken OE, Haverich A. Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg. 2002;23:475-485.
8. Huynh T, Abraham G, Murray J, Brockback K, Hagen PO, Sullivan S. Remodelling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol. 1999;17:1083-1086.
9. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science. 1986;231:397-400.
10. Niklason LE, Gao J, Abbot WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science.1999;284:489-493.
11. Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J, Langer R. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA.2003;100:12741-12746.
12. Shin'oka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacanti JP, Mayer JE. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg. 1998;115:536-546.
13. L'Heureux N, Pâquet S, Labbé R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J. 1998;12:47-56.
14. Atala A, Kim W, Paige KT, Vacanti CA, Retik AB. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J Urol. 1994;152;641-643.
15. Bent AE, Tutrone RT, McLennan MT, Lloyd LK, Kennelly MJ, Badlani G. Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol Urodyn. 2001;20:157-165.
16. Dar A, Shachar M, Leor J, Cohen S. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng. 2002;80:305-312.
17. Gross JD, Constantinidis I, Sambanis A. Modeling of encapsulated cell systems. J Theor Biol. 2007;244:500-510.
18. Li X, Liu T, Song K, Yao L, Ge D, Bao C, Ma X, Cui Z. Culture of neural stem cells in calcium alginate beads. Biotechnol Prog. 2006;22:1683-1689.
19. Maquire T, Novik E, Schloss R, Yarmush M. Alginate-PLL microencapsulation: effect on the differentiation of embryonic cells into hepatocytes. Biotechnol Bioeng. 2005;93:581-591.
20. Markusen JF, Mason C, Hull DA, Town MA, Tabor AB, Clements M, Boshoff CH, Dunnill P. Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. Tissue Eng. 2006;12:822-830.
21. Paige KT, Cima LG, Yaremchuk MJ, Vacanti JP, Vacanti CA. Injectable cartilage. Plast Reconstr Surg. 1995;96:1390-1398.
22. Rowley JA, Mooney DJ. Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res. 2002;60:217-223.
23. Zhou S, Cui Z, Urban JPG. Factors influencing the oxygen concentration gradient from the synovial surface of articular cartilage to the cartilage-bone interface. Arthritis Rheum. 2004;50: 3915-3924.
24. Dvir T, Levy O, Shachar M, Granot Y, Cohen S. Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly. Tissue Eng. 2007;13:2185-2193.
25. Mason C, Town MA. Method for forming hardened sheets and tubes. W. I. P. O. Patent, W. O. 02/077336, 2002.
26. Mason C, Markusen JF, Town MA, Dunnill P, Wang RK. The potential of optical coherence tomography in engineering of the living tissue. Phys Med Biol. 2004;49:1097-1115.
27. Brown DA, MacLellan WR, Laks H, Dunn JCY, Wu BM, Beygui RE. Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue. Biotechnol Bioeng. 2007;97: 962-975.
28. Cho CH, Park J, Nagrath D, Tilles AW, Berthiaume F, Toner M, Yarmush ML. Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures. Biotechnol Bioeng. 2007;97:188-199.
29. Chow DC, Wenning LA, Miller WM, Papoutsakis ET. Modelling pO2 distributions in the bone marrow hematopoietic compartment. II. Modified kroghian models. Biophys J. 2001;81: 685-696.
30. Dulong J, Legallais C. A theoretical study of oxygen transfer including cell necrosis for the design of a bioartificial pancreas. Biotechnol Bioeng. 2007;96:990-998.
31. Ma CYJ, Kumar R, Xu XY, Mantalaris A. A combined fluid dynamics, mass transport and cell growth model for a threedimensional perfused bioreactor for tissue engineering of haematopoietic cells. Biochem Eng J. 2007:35:1-11.
32. Malda J, Rouwkema J, Martens DE, le Comte EP, Kooy FK, Tramper J, van Blitterswijk A, Riesle J. Oxygen gradients in tissue-engineered Pegt/Pbt cartilaginous constructs: measurement and modelling. Biotechnol Bioeng. 2004;86:9-18.
33. Pathi P, Ma T, Locke BR. Role of nutrient supply on cell growth in bioreactor design for tissue engineering of hematopoietic cells. Biotechnol Bioeng. 2005;89:743-758.
34. Patzer JF. Oxygen consumption in a hollow fiber bioartificial liver-revisited. Artif Organs. 2004;28:83-98.
35. Radisic M, Deen W, Langer R, Vunjak-Novakovic G. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol.2005;288:H1278-H1289.
36. Sengers BG, van Donkelaar CC, Oomens CWJ, Baaijens FPT. Computational study of culture conditions and nutrient supply in cartilage tissue engineering. Biotechnol Prog. 2005;21:1252-1261.
37. Tziampazis E, Sambanis A. Tissue engineering of a bioartificial pancreas: modeling the cell environment and device function. Biotechnol Prog. 1995;11:115-126.
38. Ye H, Das DB, Triffitt JT, Cui Z. Modelling nutrient transport in hollow fibre membrane bioreactors for growing three-dimensional bone tissue. J Membr Sci. 2006;272:169-178.
39. Mehta K, Linderman JJ. Model-based analysis and design of a microchannel reactor for tissue engineering. Biotechnol Bioeng.2006;94:596-609.
40. Woodley JM, Titchener-Hooker NJ. The use of windows of operation as a bioprocess tool. Bioprocess Eng. 1996;14:263-268.
41. Holzapfel GA., Sommer G, Gasser CT, Regitnig P. Determination of layer-specific mechanical properties of human coronary arteries with nonatherosclerotic intimal thickening and related constitutive modeling. Am J Physiol Heart Circ Physiol.2005;289:2048-2058.
42. Palsson B, Bhatia SN, editors. Tissue Engineering. London: CRC Press; 2004:216.
43. Martens DE, Sipkerna EM, de Gooijer CD, Beuvery EC, Tramper JA. Combined cell-cycle and metabolic model for the growth of hybridoma cells in steady-state continuous culture. Biotechnol Bioeng. 1995;48:49-65.
44. Miller WM, Blanch HW, Wilke CR. A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: effect of nutrient concentration, dilution rate, and pH. Biotechnol Bioeng. 1988;32:947-965.
45. Dahl SLM, Rhim C, Ying CS, Niklason LE. Mechanical properties and compositions of tissue-engineered and native arteries. Ann Biomed Eng. 2007;35:348-355.
46. Peng C, Palsson BO. Determination of specific oxygen uptake rates in human hematopoietic cultures and implications for bioreactor design. Ann Biomed Eng. 1996;24:373-381.
47. Zeng AP, Hu WS, Deckwer WD. Variation of stoichiometric ratios and their correlation for monitoring and control of animal cell cultures. Biotechnol Prog. 1998;14:434-441.
48. Zhao F, Pathi P, Grayson W, Xing Q, Locke BR, Ma T. Effects of oxygen transport on 3-D human mesenchymal stem cell metabolic activity in perfusion and static cultures: experiments and mathematical model. Biotechnol Prog. 2005;21:1269-1280.
49. Xie L, Wang DI. Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies. Biotechnol Bioeng. 1993;43:1175-1189.
50. Patel SD, Papoutsakis ET, Winter JN, Miller WM. The lactate issue revisited: novel feeding protocols to examine inhibition of cell proliferation and glucose metabolism in hematopoietic cell cultures. Biotechnol Prog. 2000;16:885-892.
51. Schneider M, Marison W, von Stockar U. The importance of ammonia in mammalian cell culture. J Biotech. 1996;46:161-185.
52. Coulson JM, Richardson JF, editors. Chemical Engineering, Vol. 1. Oxford: Butterworth-Heinemann; 1999:597-598.
53. Palsson B, Hubbel JA, Plonsey R, Bronzino JD, editors. Tissue Engineering: Principles and Applications in Engineering Series. London: CRC Press; 2003:14-16.
54. Ishikawa Y, Ito T. Kinetics of hematopoietic stem cells in a hypoxic culture. Eur J Haematol. 1988;40:126-129.
55. Schmidt RF, Thews G, editors. Human Physiology. Heidelberg, Germany: Spinger-Verlag; 1989:490, 529, 533.
56. Yamamoto K, Sokabe T, Watabe T, Miyazono K, Yamashita JK, Obi S, Ohura N, Matsushita A, Kamiya A, Ando J. Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. Am J Physiol Heart Circ Physiol. 2005;288:H1915-H1924.
57. Wang H, Riha G, Yan S, Li M, Chai H, Yang H, Yao Q, Chen C. Shear stress induces enthothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler Thromb Vasc Biol. 2005;25:1817-1823.
58. Huang H, Nakayama Y, Qin K, Yamamoto K, Ando J, Yamashita J, Itoh H, Kanda K, Yaku H, Okamoto Y, Nemoto Y. Differentiation from embryonic stem cells to vascular wall cells under in vitro pulsatile flow loading. J Artif Organs. 2005; 8:110-118.
59. Lee CSD, Gleghorn JP, Choi NW, Cabodi M, Stroock AD, Bonassar L. Integration of layered chondrocyte-seeded alginate hydrogel scaffolds. Biomaterials. 2007;28:2986-2993